Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Status Not yet recruiting

Clinical Trial Summary

After resection of lymph node positive breast cancer, the injection duration and timing of Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC (Taxotere, Adriamycin, cyclophosphamide) chemotherapy.

Clinical Trial Description

The duration and the injection timing of G-CSF are effective in the prevention of neutropenia, incidence of infection and non hematologic toxicity. With the TAC chemotherapy after resection of breast cancer, the G-CSF early injection versus late injection could change the frequency of neutropenia. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Neutropenia

Clinical Trial Details

NCT number	NCT01571518
Study type	Interventional
Source	Sunchonhang University
Contact	Chul Wan Lim, M.D., Ph.D
Phone	82-32-621-5114
Email	cylim@soonchunhyang.com
Status	Not yet recruiting
Phase	Phase 4
Start date	April 2012
Completion date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02452034` - Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)	Phase 1
Not yet recruiting	`NCT02806557` - Profiling Neutrophil Counts in Patients on Chemotherapy	N/A
Not yet recruiting	`NCT01714557` - Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation	N/A
Completed	`NCT01371656` - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation	Phase 3
Active, not recruiting	`NCT00020865` - Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia	Phase 3
Completed	`NCT00257790` - The Tobramycin Study	Phase 4
Completed	`NCT00020371` - BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy	Phase 1
Terminated	`NCT00005787` - Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma	Phase 1
Completed	`NCT00001533` - Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine	Phase 1
Completed	`NCT05585463` - Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Not yet recruiting	`NCT02238873` - Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma	Phase 3
Completed	`NCT01058993` - AMD 3100 for Treatment of Myelokathexis	Phase 1
Completed	`NCT00771810` - Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer	Phase 2
Completed	`NCT00771433` - G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer	Phase 2
Terminated	`NCT00529282` - A Study of Ceftobiprole in Patients With Fever and Neutropenia.	Phase 3
Completed	`NCT00770172` - G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy	Phase 3
Active, not recruiting	`NCT00030758` - Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer	Phase 4
Completed	`NCT00001790` - Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia	Phase 1
Completed	`NCT00002693` - Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia	Phase 1
Active, not recruiting	`NCT04154488` - A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorders	Phase 1/Phase 2